Inventor · disambiguated record
Mika Aoyagi-Scharber
Also filed as: AOYAGI-SCHARBER MIKA
12 granted patents·5 pending applications·124 citations·filing 2008–2025
92Inventor score
Top patents by PatentIndex Score
17 records- 0194US9834587B2Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2015·Granted Dec 5, 2017·6 cites·12 claims
- 0294US9834588B2Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2015·Granted Dec 5, 2017·7 cites·12 claims
- 0394US8198242B2Variants of C-type natriuretic peptideWENDT DANIEL J·Filed 2010·Granted Jun 12, 2012·46 cites·17 claims
- 0493US10301369B2Nucleic acids encoding targeted therapeutic lysosomal enzyme fusion proteinsBIOMARIN PHARM INC·Filed 2017·Granted May 28, 2019·5 cites·17 claims
- 0592US9771408B2Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2015·Granted Sep 26, 2017·4 cites·12 claims
- 0691US9845346B2Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2015·Granted Dec 19, 2017·4 cites·12 claims
- 0791US9376480B2Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2013·Granted Jun 28, 2016·6 cites·21 claims
- 0890US11254725B2Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2019·Granted Feb 22, 2022·2 cites·13 claims
- 0990US8598121B2Variants of C-type natriuretic peptideWENDT DANIEL J·Filed 2012·Granted Dec 3, 2013·15 cites·14 claims
- 1090US8377884B2Variants of C-type natriuretic peptidesBIOMARIN PHARM INC·Filed 2008·Granted Feb 19, 2013·27 cites·24 claims
- 1188USRE48267EVariants of C-type natriuretic peptideBIOMARIN PHARM INC·Filed 2017·Granted Oct 20, 2020·2 cites·76 claims
- 1280US2022127326A1Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses ThereofBIOMARIN PHARM INC·Filed 2022·Application pending·0 cites
- 1377US2025388644A1Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2025·Application pending·0 cites
- 1460US2024318156A1Compositions of beta-hexosaminidase variants and uses thereofBIOMARIN PHARM INC·Filed 2022·Application pending·0 cites
- 1559US2017051033A1Variants of C-Type Natriuretic PeptideBIOMARIN PHARM INC·Filed 2016·Application pending·0 cites
- 1656USRE46707EVariants of C-type natriuretic peptideBIOMARIN PHARM INC·Filed 2015·Granted Feb 13, 2018·0 cites·17 claims
- 1754US2016256553A1Variants of C-Type Natriuretic PeptideBIOMARIN PHARM INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →